CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 80 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $80,000 | -25.9% | 22,832 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $108,000 | -28.9% | 22,832 | -51.2% | 0.00% | -60.0% |
| Q2 2020 | $152,000 | -59.7% | 46,745 | -36.5% | 0.01% | -67.7% |
| Q1 2020 | $377,000 | -32.4% | 73,634 | -39.9% | 0.03% | -36.7% |
| Q4 2019 | $558,000 | -19.5% | 122,461 | +8.1% | 0.05% | -23.4% |
| Q3 2019 | $693,000 | +23.8% | 113,250 | +23.2% | 0.06% | +25.5% |
| Q2 2019 | $560,000 | +50.9% | 91,908 | +37.6% | 0.05% | +41.7% |
| Q1 2019 | $371,000 | +106.1% | 66,799 | +109.7% | 0.04% | +38.5% |
| Q4 2018 | $180,000 | – | 31,850 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |